Aussie investor love affair with healthcare continues with EBR Systems’ $110m ASX IPO
EBR Systems' WiSE technology is world's first and only wireless, inside the left ventricle of the heart, pacing system for heart failure EBR's planned $110m ASX initial public offering on 24th November 2021, strongly supported by new and existing institutional shareholders Capital to enable completion of pivotal study, targeting FDA submission for approval in 2023 followed...
Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments
NANJING, China, Nov. 23, 2021 /PRNewswire/ -- On November 17, 2021, Simcere Pharmaceutical Group Limited (2096.HK) announced that the company has reached collaboration agreement with the Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS), to develop novel antiviral drugs for COVID-19. During preclinical studies, the compound candidates for these drugs have been shown to have strong inhibitory...
Gilead Sciences, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP), and the World Hepatitis Alliance (WHA) Collaborate to Support Elimination of Hepatitis by 2030
Today, an Estimated 257 Million People Live With Hepatitis B Globally. The World Health Organization Has Categorized Viral Hepatitis as a Public Health Threat and Has Set Targets for Elimination by 2030. Despite National Immunization Programs Being Implemented in the 1980s, More Than 50% of the Disease Burden Is Borne by the Asia Pacific Region and...
Philips Foundation announces partnership with Singapore Heart Foundation to increase access to heart care in Singapore
The year-long partnership, involving the funding of cardiac rehabilitation infrastructure, CPR training and Philips AED equipment, and community outreach programs, aims to improve cardiac incident outcomes and improve health inequality. The SHF-Philips Foundation Heart Wellness Centre's location, in an area with a high number of elderly in the lower-income group, reflects Philips Foundation's commitment to alleviating health...
Happiness Development Reached Cooperation with Shanghai Automobile Trading Co., Ltd
NANPING, China, Nov. 23, 2021 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, announced today that its automobile sales brand, Taochejun's subsidiary, has reached a sales agreement with Shanghai Automobile Trading Co., Ltd, a wholly owned...
Trajan Group acquires Axel Semrau GmbH
MELBOURNE, Australia, Nov. 22, 2021 /PRNewswire/ -- Global analytical science and device company Trajan Group Holdings Limited (ASX: TRJ) (Trajan or the Company) has completed the acquisition of Axel Semrau GmbH & Co. KG and Semrau Immobilien GmbH & Co. KG, the private business and properties of "Axel Semrau" based in Sprockhövel, Germany...
Arctic Vision Announces First Patient Dosed in Phase III Study of ARVN001 for Treatment of Macular Edema Associated with Uveitis (UME)
First-in-class SCS Microinjection therapy First clinical registration study and potentially the first approved drug in China targeting macular edema associated with uveitis U.S. FDA approved for treatment of macular edema associated with uveitis SHANGHAI, Nov. 22, 2021 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on innovative ophthalmic...
Getinge accelerates growth and productivity to reach new financial targets
GOTHENBURG, Sweden, Nov. 22, 2021 /PRNewswire/ -- "Getinge's new financial targets for 2022-2025, an annual organic net sales growth of 4-6% and adjusted EPS growth of above 10% on average throughout the period, is well in line with our strategy and ambitions", says Mattias Perjos, President & CEO at Getinge. "Our continued organic growth and improved margins will be...
Ascentage Pharma’s Olverembatinib Granted Orphan Designation by the European Commission for the Treatment of Chronic Myeloid Leukemia
SUZHOU, China, and ROCKVILLE, MD., Nov. 22, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the European Commission (EC) has granted the company's novel drug candidate, olverembatinib (HQP1351), an Orphan Designation for the...
TenNor Reports Positive Results of TNP-2092 Capsule for the Treatment of Liver Cirrhosis Hyperammonemia
SUZHOU, China, Nov. 22, 2021 /PRNewswire/ -- TenNor Therapeutics reports positive top-line results for TNP-2092 Capsule from a phase II clinical trial for the treatment of hyperammonemia/hepatic encephalopathy in patients with liver cirrhosis. TNP-2092 Capsule is an investigational new drug product currently under clinical development for the treatment of Hepatic Encephalopathy (HE) and Irritable Bowel Syndrome with Diarrhea (IBS-D)....
